Eargo Inc (NAS:EAR)
$ 2.57 0 (0%) Market Cap: 53.36 Mil Enterprise Value: 14.99 Mil PE Ratio: 0 PB Ratio: 1.18 GF Score: 35/100

Eargo Inc at UBS Global Healthcare Virtual Conference Transcript

May 24, 2021 / 03:00PM GMT
Release Date Price: $664 (+3.23%)
Matthew Charles Taylor;Christian Gormsen
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices;Eargo, Inc. - CEO, President &amp

Okay. Great. Good morning, and welcome to our next session. I'm Matt Taylor, UBS' U.S. medical supplies and devices analyst. And I'm pleased to be joined by management from Eargo for this session. So we're going to have a 45-minute fireside chat Q&A. We've got lots of questions lined up. But if you have any that you guys to focus on or lob in, just e-mail me or there's a feature in the presentation in where you can ask a question through the platform.

So without further ado, let me introduce the management from Eargo, we've got Christian Gormsen, who's the President and CEO of the company. We've also got -- for the phone-a-friend feature, I guess, Adam Laponis, who is in the background, the CFO, in case there's some technical financial questions that need to answer.

And with that, Christian, just want to say thank you for the time for joining us, and welcome to this presentation.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot